Back
Corporate News
Novartis India seeks shareholder approval for name change and Memorandum alignment
17-Aug-2026, 09:12
Novartis India Limited announced that its Board of Directors approved the adoption of a new Memorandum of Association to align with the Companies Act, 2013, and a proposal to change the company’s name, both subject to shareholder approval at the upcoming Annual General Meeting. The decisions were made at a board meeting held on Monday, August 17, 2026, and also included an amendment to the Notice of the 78th Annual General Meeting previously approved on August 7, 2026.
Novartis India Limited announced that its Board of Directors approved the adoption of a new Memorandum of Association to align with the Companies Act, 2013, and a proposal to change the company’s name, both subject to shareholder approval at the upcoming Annual General Meeting. The decisions were made at a board meeting held on Monday, August 17, 2026, and also included an amendment to the Notice of the 78th Annual General Meeting previously approved on August 7, 2026.